en

PRODUCT DETAIL

IMOVAX D.T. ADULT

Code 33919
MA number 59/0936/96-S
Product Form: sus iru 1x0,5 ml (striek.inj.skl.napln.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
MAH, country: Sanofi Winthrop Industrie, France
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07A BACTERIAL VACCINES
J07AM Tetanus vaccines
J07AM51 Tetanus toxoid, combinations with diphtheria toxoid
Shelf life: 36
Container: glass pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.12.1996
Pediatric indication: Yes
Pediatric posology: Yes
SPC: SPC_IMOVAX D.T. ADULT_01.2025.pdf  
PIL: PIL_IMOVAX D.T. ADULT_01.2025.pdf  
Safety feature Yes
Data update: 10.01.2025
eu-flag.png sk-flag.png